Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 1
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation.
Iturriaga-Goyon E, Vivanco-Rojas O, Magaña-Guerrero FS, Buentello-Volante B, Castro-Salas I, Aguayo-Flores JE, Gracia-Mora I, Rivera-Huerta M, Sánchez-Bartés F, Garfias Y. Iturriaga-Goyon E, et al. Among authors: rivera huerta m. Int J Mol Sci. 2021 Dec 5;22(23):13150. doi: 10.3390/ijms222313150. Int J Mol Sci. 2021. PMID: 34884955 Free PMC article.
Toxicity Evaluation of a Novel Rapamycin Liposomal Formulation After Subconjunctival and Intravitreal Injection.
Salas-Ambrosio PJ, Bernad-Bernad MJ, Linares-Alba MA, García-Santisteban R, Tonix-Aburto LA, Ornelas-Lobato GJ, Gracia-Mora I, Rivera-Huerta M, Sánchez-Bartez F, Rico-Morales H, García-Sánchez GA. Salas-Ambrosio PJ, et al. Among authors: rivera huerta m. J Ocul Pharmacol Ther. 2021 Jun;37(5):261-276. doi: 10.1089/jop.2020.0108. Epub 2021 Mar 10. J Ocul Pharmacol Ther. 2021. PMID: 33691483
Preparation and Evaluation of Mebendazole Microemulsion for Intranasal Delivery: an Alternative Approach for Glioblastoma Treatment.
Mena-Hernández J, Jung-Cook H, Llaguno-Munive M, García-López P, Ganem-Rondero A, López-Ramírez S, Barragán-Aroche F, Rivera-Huerta M, Mayet-Cruz L. Mena-Hernández J, et al. Among authors: rivera huerta m. AAPS PharmSciTech. 2020 Sep 27;21(7):264. doi: 10.1208/s12249-020-01805-x. AAPS PharmSciTech. 2020. PMID: 32980937
Preclinical evidences of safety of a new synthetic adjuvant to formulate with the influenza human vaccine: absence of subchronic toxicity and mutagenicity.
Cervantes-Torres J, Gracia-Mora I, Segura-Velazquez R, Montero-Montoya R, Espinosa-Aguirre J, E Gonsebatt M, Camacho-Carranza R, Rivera-Huerta M, Sanchez-Bartez F, Tinoco-Méndez M, Ostrosky-Wegman P, Fragoso G, Sciutto E. Cervantes-Torres J, et al. Among authors: rivera huerta m. Immunopharmacol Immunotoxicol. 2019 Feb;41(1):140-149. doi: 10.1080/08923973.2019.1566359. Epub 2019 Feb 4. Immunopharmacol Immunotoxicol. 2019. PMID: 30714433